Cardionomic: 1st U.S. Patient Enrolled in Cardionomic's CPNS System Pilot Study

Cardionomic, Inc., a Minneapolis medical device company, announced initial U.S. enrollment in their global Cardiac Pulmonary Nerve Stimulation (CPNS) Pilot Study (NCT04814134). The study is evaluating the safety and performance of the CPNS System in patients suffering from acute decompensated heart failure (ADHF), defined as new or worsening symptoms of heart failure. The first U.S. [...] The post 1st U.S. Patient Enrolled in Cardionomic's CPNS System Pilot Study appeared first on Medical Device News Magazine.